Recent progress of palmitoyl transferase DHHC3 as a novel antitumor target.
Sign Up to like & getrecommendations! Published in 2022 at "Future medicinal chemistry"
DOI: 10.4155/fmc-2021-0192
Abstract: DHHC3 is a DHHC-family palmitoyl acyltransferase that is responsible for many mammalian palmitoylation events. By regulating the posttranslational modification of its specific substrates, DHHC3 has shown a strong protumor effect in various cancers. In this… read more here.
Keywords: antitumor target; dhhc3; recent progress;